Asset Details
Do you wish to reserve the book?
Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain
Do you wish to request the book?
Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain
2014
Overview
Rationale
Carrageenan-induced hyperalgesia is a widely used pain model in rodents. However, characteristics of carrageenan-induced hyperalgesia and effects of analgesic drugs under these conditions are unknown in nonhuman primates.
Objective
The aims of this study were to develop carrageenan-induced hyperalgesia in rhesus monkeys and determine the efficacy and potency of agonists selective for the four opioid receptor subtypes in this model versus acute pain, as compared to non-steroidal anti-inflammatory drugs (NSAIDs).
Results
Tail injection of carrageenan produced long-lasting thermal hyperalgesia in monkeys. Systemically administered agonists selective for opioid receptor subtypes, i.e., fentanyl (mu/MOP), U-50488H (kappa/KOP), SNC80 (delta/DOP) and Ro 64-6198 (nociceptin/orphanin FQ/NOP) dose-dependently attenuated carrageenan-induced thermal hyperalgesia with different potencies. In absence of carrageenan, these agonists, except SNC80, blocked acute thermal nociception. Opioid-related ligands, especially Ro 64-6198, were much more potent for their antihyperalgesic than antinociceptive effects. Both effects were mediated by the corresponding receptor mechanisms. Only fentanyl produced scratching at antihyperalgesic and antinociceptive doses consistent with its pruritic effects in humans, illustrating a translational profile of MOP agonists in nonhuman primates. Similar to SNC80, systemically administered NSAIDs ketorolac and naproxen dose-dependently attenuated carrageenan-induced hyperalgesia but not acute nociception.
Conclusion
Using two different pain modalities in nonhuman primates, effectiveness of clinically available analgesics like fentanyl, ketorolac and naproxen was distinguished and their efficacies and potencies were compared with the selective KOP, DOP, and NOP agonists. The opioid-related ligands displayed differential pharmacological properties in regulating hyperalgesia and acute nociception in the same subjects. Such preclinical primate models can be used to investigate novel analgesic agents.
Publisher
Springer Berlin Heidelberg,Springer,Springer Nature B.V
Subject
/ Analgesics, Opioid - therapeutic use
/ Animals
/ Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
/ Benzamides - therapeutic use
/ Biomedical and Life Sciences
/ Complications and side effects
/ Dose-Response Relationship, Drug
/ Female
/ Hyperalgesia - chemically induced
/ Imidazoles - therapeutic use
/ Inflammation - complications
/ Ligands
/ Macaca
/ Male
/ Nociceptive Pain - drug therapy
/ Nonsteroidal anti-inflammatory drugs
/ Opioids
/ Pain Measurement - drug effects
/ Piperazines - therapeutic use
/ Primates
